Psychedelic Agents in Creative Problem-Solving: A Pilot Study
This is the first known study (1966, n=27) in which creativity under influence of psychedelics (mescaline, 200mg) was being studied in professionals and within a very positive/guiding setting.
Authors
- Fadiman, J.
- Harman, W. W.
- McKim, R. H.
Published
Abstract
Based on the frequently reported similarities between creative and psychedelic (drug-induced, consciousness-expansion) experiences, a preliminary study was conducted to explore the effects of psychedelic agents (LSD-25, mescaline) on creative problem-solving ability. Twenty-seven professionally employed males were given a single psychedelic experience in 1 of 7 small groups (ns = 3 or 4) following extensive selection and preparatory procedures. This drug-induced problem-solving session was carefully structured with particular focus on establishing Ss' expectancies and a psychosocial milieu conducive to creative activity. Tentative findings based on tests of creativity, on subjective reports and self ratings, and on the utility of problem solutions suggested that, if given according to this carefully structured regimen, psychedelic agents seem to facilitate creative problem-solving, particularly in the “illumination phase.” The results also suggest that various degrees of increased creative ability may continue for at least some weeks subsequent to a psychedelic problem-solving session.
Research Summary of 'Psychedelic Agents in Creative Problem-Solving: A Pilot Study'
Introduction
Earlier research had noted phenomenological similarities between psychedelic states (produced by agents such as LSD-25, mescaline and psilocybin) and certain stages of the creative process, particularly the ‘‘illumination’’ or insight phase. The literature cited by the investigators argues that psychedelic experiences can reduce psychological defensiveness, increase tolerance for ambiguity, expand perceptual and associative span, and produce vivid imagery — attributes long linked to creativity. Against this theoretical backdrop, the investigators emphasise that the effects of these drugs are highly context-dependent: expectancies of the participant and experimenter, the psychosocial milieu of the session, and preparatory procedures (set and setting) strongly shape the ensuing experience and any task performance changes. Harman and colleagues designed a pilot study to explore three related empirical questions: (1) whether a single, carefully structured psychedelic session could enhance creative problem-solving and, if so, what objective and subjective evidence would support that enhancement; (2) whether problems worked on during such sessions would yield concrete, valid, and pragmatically useful solutions as judged by industrial or scientific criteria; and (3) whether any enhancement in creative functioning persisted after the acute drug effects. The investigators framed the psychedelic agent as one component of an intentionally organised procedure that also included selection, preparation, and a supportive session milieu rather than attempting to isolate purely pharmacological effects.
Methods
This was an exploratory, within-subjects pilot study using professionally employed participants chosen for occupations that normally require creative problem-solving (engineering, physics, mathematics, architecture, industrial design and related fields). The extracted text reports 27 participants selected on the criteria of occupational requirement for creativity, psychological normality as judged by a psychiatric interview, and motivation to apply any solutions in their work. However, there is an inconsistency in the extraction: selection is described as 27 males, yet some later test-score descriptions include female participants; the extract does not resolve that discrepancy. Preparatory procedures were substantial. Each participant selected one or more real professional problems to work on and received a psychiatric examination and at least one pre-session interview; participants who would be in the same session also met together beforehand. Investigators emphasised establishing rapport, shaping expectancies that the session would facilitate focused problem work rather than distractive visions, and detailing the session agenda. Group sessions were used (seven sessions reported, group size 3–4), and two non-drug observers attended each session. The pharmacological regimen reported for the seven sessions primarily used mescaline sulfate at about 200 mg (noted as roughly equivalent to 100 mcg LSD). During sessions participants spent an initial 2–3 hours quietly listening to music with stereo earphones and were encouraged to relax, minimise analytical control, and accept experience. Testing was then undertaken (alternate forms had been administered pre-session), followed by 3–4 hours of individual problem-solving, typically in silence. Sessions concluded with opportunities to share experiences; participants were taken home later with a sedative available if needed. Assessment combined objective and subjective measures. Performance was evaluated by a battery of standardized tests of creative ability administered several days before and again during the acute drug phase; the authors report three tests with split-half reliabilities over 0.90, and alternate forms were counterbalanced. One named instrument was the Witkin Embedded Figures Test. Participants also completed immediate post-session subjective reports and questionnaires rating nine characteristics relevant to creative problem-solving on a −2 to +2 scale. Follow-up interviews and questionnaires were conducted weeks after the session to assess post-session creative functioning and the pragmatic validity and acceptance of session-derived solutions. Solutions were additionally subjected to external pragmatic judgement (industry/science endorsement) where possible. Statistical testing of pre/post changes was reported with significance levels (e.g. p-values) for the measures detailed in the Results.
Results
Objective test performance showed measurable improvement on selected instruments administered during the acute drug phase compared with pre-session testing. One unnamed test showed a significant change (reported as x" = 6.00, df = 26, p < 0.02), with about half of participants reporting the alternate form taken during the psychedelic session seemed easier and taking roughly half the time; about a third reported using a more visual approach and improved their scores or speed. A ceiling effect was noted for that instrument. The Witkin Embedded Figures Test data (reported for n = 14, with the extraction indicating 4 females and 10 males) showed pronounced improvement: mean time to locate 12 figures decreased from 404 seconds pre-session to 234 seconds during the session. Nearly every participant improved; the change was statistically significant (x" = 8.64, df = 13, p < 0.01). Individual speed gains were reported up to 200%. The investigators interpret this as enhanced ability to recognise patterns, reduce visual distraction and maintain visual memory, a shift described as movement toward ‘‘field independence.’' Subjective ratings and reports complemented the objective tests. Participants rated nine characteristics relevant to creative problem-solving on a −2 to +2 scale; the extraction does not present the full table of average ratings but states that selected visual and verbal skills were enhanced for some participants and that the pattern of test results was consistent with increased intuitive skills and decreased defensiveness. From open-ended reports the investigators extracted 11 experiential modes or strategies reported as heightened during the sessions: reduced inhibition and anxiety; capacity to structure problems in a broader context; increased fluency and flexibility of thinking; heightened visual imagery and fantasy; sustained concentration and absorption; empathy with external processes and objects; empathy with people; access to unconscious resources and memory; associative combination of dissimilar elements; a strong appetite for closure and elegance; and related creative attitudes. Representative participant comments included short remarks such as "There was no fear, no worry..." describing lowered inhibition, and vivid visual descriptions of problem models. Pragmatic outcomes were tracked across the problems participants attempted in sessions. Examples of concrete solutions produced included a vibratory microtome redesign, a commercial building design accepted by a client, space-probe experiments to measure solar properties, an electron-accelerator beam-steering device, improvements to magnetic tape recorders, chair and furniture designs accepted by manufacturers, a letterhead design adopted by a customer, a mathematical theorem about NOR-gate circuits, and a conceptual photon model found useful. Of 44 problems reported in the questionnaire follow-up: 1 had no further activity after a month, 20 opened new avenues for further investigation, 1 had a developmental model authorised to test the solution, 2 had working models completed, 6 had solutions accepted for construction or production, 10 were partial solutions being developed or applied, and 4 had no solution obtained. Regarding longer-term effects, the investigators report a short follow-up (variously described in the extraction as about 2 weeks and also as 3–6 weeks for different components) in which most participants described persistent improvements in concentration, visual problem perception, and reduced inhibition. The authors qualify these findings as tentative and call for more objective, systematic confirmation.
Discussion
Harman and colleagues interpret the findings as preliminary evidence that when a psychedelic session is carefully structured to optimise set and setting, a single psychedelic experience can facilitate specific aspects of creative problem-solving, especially those associated with ‘‘illumination’’ or sudden insight. They note that objective test improvements and numerous subjective reports converged with pragmatic outcomes — several session-derived solutions were carried forward, developed, or accepted by clients or manufacturers — supporting the practical relevance of the reported enhancements. The investigators emphasise the centrality of contextual factors: expectancies of participants and experimenters, preparatory interviews, and the psychosocial atmosphere appear crucial in channeling the drug state toward creative work rather than distraction. They explicitly state that their design does not attempt to disentangle the relative contributions of the pharmacologic agent, expectancy and motivation, because blinding or placebo control is difficult in this domain; even experienced investigators and naïve participants tend to detect whether a psychedelic has been administered, altering expectancies. Limitations acknowledged by the authors include the exploratory pilot nature of the study, the small and selective sample drawn from professional occupations, potential inconsistencies in reporting (for example, sex composition in some test data is unclear in the extracted text), and the lack of control conditions that would isolate pharmacological effects from expectancy and setting. They describe the results as tentative and stress the need for larger, more diverse samples, expanded and counterbalanced test batteries with alternate forms, and systematic post-session follow-up testing to document the duration and generalisability of any effects. For future work the investigators recommend extending the procedure to a broader range of specialties, increasing sample size, using more comprehensive standardised assessments administered before and at multiple time points after sessions, and developing more rigorous methods to evaluate the pragmatic validity of solutions. They characterise this study primarily as a methodological and conceptual step toward more comprehensive research on psychedelic agents and creative problem-solving.
Study Details
- Study Typeindividual
- Populationhumans
- Characteristicsopen labelinterviews
- Journal
- Compound